HOW DOES SEGI MAKE MONEY??? Well if "The Eye of the

New Post Public Reply Private Reply Replies (1) Message Board
Angel PowerPuncher #58

HOW DOES SEGI MAKE MONEY???

Well if "The Eye of the Storm" continues getting Academy Award mentions for Davis, Rampling, and Rush it will bode very well for the films revenue potential. Look at what academy award (Oscar) winning film "Winter's Bone" did with an initial 4 theater release and maximum theater count of 141.

http://www.the-numbers.com/movies/2010/WBONE.php

If "Eye of the Storm" can perform comparably to Winter's Bone performance of $6.5 million domestic box office and $3.7 Million on Home Video that would be an enormous win for SEGI. A $6.5 million box office would put probably at least $1 Million back in SEGI's coffers for continued acquisition of other films.

Otherwise I will explain simply how film distributors make their money below.

As an investor in SEGI it doesn't really matter what the investors in the film itself make or the cost to produce the film. What matters is the distributors percentage cut and if they had to pay anything in advance to acquire the distribution rights of the property. Film Producers have the largest risk of losing money on a film. Far more risk than distributors as distributors are the last money in the investment and the first money out. Outside of the theater chains who take their cut first at the ticket window.

Every distribution deal is in effect a business of its own. But you can use base percentages and get a decent estimation of what a company like SEGI could earn from being the distributor on a film. They also will make more money from managing the P&A fund. I will try to provide a basic explanation of this, and I will use low end numbers in these estimations, as most full service distributors actually make at least 30-45% but my number is based on a low end service deal of 15%.

Every movie distribution deal is different as everything is negotiated between each distributor and the film makers, but P&A (Print & Advertising) funding gets paid back first after the theatrical 50/50 split. Then distributors make anywhere from 15% to 40% of gross revenues.

So just as an example. Using the film "Insidious" as an example, and pretending that Sycamore acquired the distribution rights of that film. Again this is just pretending that Sycamore Entertainment released "Insidious"

SEGI would have successfully released the film domestically to the tune of $54 Million. Also lets assume a $10 Million P&A fund was used for the film which is probably a bit high. Cause Film prints and delivery cost on average are approximately $1000 for each theater location (This is the cost of a film print and shipping) Digital copies that are shipped on a hard drive to theaters with digital projectors can cost as little as $250, and then associated advertising for a few weeks prior. I'm assuming P&A was probably around $5 to $7.5 Million. But $10 Million should be very a safe over estimated barometer.

http://www.boxofficemojo.com/movies/?id=insidious.htm

We subtract the $10 Million P/A and we'll say a $1 to $2.5 Million fee to pay the fund investors for a total of we will say $12.5 Million.

We now have a total of $14.5 Million gross from which distributors are allowed to take any incurred expenses as well as their agreed upon distribution fee which can be anywhere from 15% to 40% but we will use 15% on the low end which is essentially the equivalence of a "service deal". Service Deals they are basically just letting film producers use their contacts, film printing accounts, and a few other

So say there were $2 Million in expenses negotiated in management fees with the films distribution such as distribution management, marketing plans, and marketing consultants that Sycamore could take off the top to pay off those expenses leaving $12.5 Million. Then there is the 15% SEGI could potentially bring in as their distribution fee which could net them $1,875,000 from the remaining $12,500,000 in this instance plus say a P&A managment fee of $500K, thus leaving the producers that made "Insidious" with $10,625,000 to cover their production budget of $1.5 Million and making the producers a $9,125,000 Million profit.

Take into account the monies made by SEGI in Distribution Fees of $2,000,000 and their 15% take of 1,875,000 and their P&A management of $500,000 then there is potential for $4,375,000.

If just $1,000,000 of this is profit (low end) and they can replicate this business across 5-8 films a year then a significant return could be foreseen. Use 5 films and $5 Million in profit annually from those films spread across an O/S of 222 Million give and EPS of $.0225

Use a low end P/E ratio of 10 and you have a $.22 stock. Use a 20 P/E and you have a $.44 stock.

Get a couple of blockbuster movies and Sycamore becomes the next Lionsgate or Summit on the distribution depth chart and your looking at a moon shot of the share price.

Keep in mind, that I did not mention anything about the monies received from Home and Video distribution. A DVD costs distributors on Average about $1 to copy. If walmart sells a DVD for $15 the price paid to SEGI would probably be around $7.50. Minus $1 production run costs there is $6.50 left to split between film producers and SEGI the distributor. SEGI using a low end assumption again of 25% but could again be as high as 405% would get approximately $1.625 per DVD.

1 Million DVD's sold would net them $1.625 Million based on that calculation.

Imagine doing this all 5 to 8 times a year for every film acquired. Sure some will be flops but some might be moderately successful. What if one was a hit? If one was a hit, Moon Shot might be an understatement.

Sycamore Entertainment Group Inc. (SEGI) Stock Research Links

SEGI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

Lawsuit Filed for Newmont Corporation (NEM) Investors

Updated Category News Views 99

Understanding the Class Action Against Newmont Corporation In recent news, investors in Newmont Corporation (NEM) are urged to take notice of a class action securities lawsuit activated by Levi & Korsinsky, LLP. This legal endeavor aims to seek restitution for shareholders impacted by alleged fraudulent activities linked to the company’s operations. What is the Class...

Continue Reading
Plains All American Pipeline Unveils Q3 2024 Distributions

Updated Category News Views 48

Quarterly Distributions Announced by Plains All American Plains All American Pipeline, L.P. (NASDAQ: PAA) and Plains GP Holdings (NASDAQ: PAGP) have just shared their quarterly distributions for the third quarter of 2024, making this an important update for shareholders and investors alike. Details of the Quarterly Distribution The companies revealed a consistent approach...

Continue Reading
FLSmidth Achieves Record Profitability in 2024 Annual Summary

Updated Category News Views 667

FLSmidth 2024 Annual Report Highlights Major Achievements On February 20, 2025, FLSmidth’s Board of Directors approved the Annual Report for 2024, showcasing significant improvements in profitability and outlining the progress made towards key transformation efforts. Major Highlights from 2024 include: Increased Mining Service order intake by 2% from the previous year,...

Continue Reading
DAX Stumbles Slightly as Mixed Trends Shape German Stocks

Updated Category News Views 226

Exploring the Mixed Signals in the German Stock Market The German stock market concluded on a mixed note recently, reflecting a variety of performance trends among different sectors. While certain sectors saw positive movement, others faced declines, illustrating the complexity of the current economic environment. DAX Performance and Sector Shifts At the closing bell in...

Continue Reading
Ray Dalio's Insights on Tech Sector Growth Amid Deregulation

Updated Category News Views 327

Understanding Ray Dalio's Economic Perspective In a recent discussion, renowned investor Ray Dalio analyzed the shifting economic landscape under the upcoming presidential administration. He highlighted the potential changes that could significantly affect how tech companies operate in a less regulated environment. Potential Changes in the Regulatory Landscape Dalio's...

Continue Reading